Protein / Gene Mouse (animal) model or Treatment | Altered PV staining/ PV+ number | Mitochondria dysfunction | Hyper/hypo-connectivty | SFARIa |
---|---|---|---|---|
Shank 3 (Shank3) Shank3B-/- | PV+ puncta surrounding pyramidal cells decreased in insular cortex of adult mice [1]c, PV downregulation in striatal Pvalb neurons at PND25 [2] | In a Fmr1 knock-in premutation mouse model resulting in Shank3 downregulation, at PND21, decreases in NADH oxidase, succinate oxidase and cytochrome c oxidase activity, as well as increased uncoupling between ATP production and electron transfer in hippocampus and cerebellum [3] | Altered local and global connectivity patterns indicative of circuit abnormalities in SHANK3-mutant macaques [4], prefrontal hypoconnectivity associated with reduced density of short-range cortical projections [5], reduced spine density in striatum of Shank3(Δex4–22)-/- mice linked to abnormal functional connectivity within the cortico-striatal-thalamic circuit [6] | 1 (Sb) |
phosphatase and tensin homolog (Pten) Pten+/- | n/a | Increase of several mitochondrial complex activities (II-III, IV and V) in mitochondria isolated from hippocampus and cerebellum (not cortex) of young (4-6 weeks) mice, not accompanied by increases in mitochondrial mass [7] | Increased axonal branching and connectivity (mPFC to basolateral amygdala axonal projections) [8], local and long-range hyper-connectivity in auditory cortex [9] | 1 (S) |
methyl CpG binding protein 2 (Mecp2) Mecp2-/- | At PND15 no PV+ cells [10] indicates delayed maturation of Pvalb neurons, but morphological hypermaturation in visual cortex is associated with increased Pvalb mRNA [11] | Increased ROS release in mitochondria isolated from hippocampus of Mecp2-/- mice [12], increased H2O2 generation in mitochondria isolated from whole brain mainly produced by dysfunctional complex II [13] | Increase of Pvalb neuron cellular and PNN structural complexity in visual cortex [14], reduced density of excitatory dendritic spines in mPFC pyramidal cells [11] | 2 (S) |
contactin associated protein-like 2 (Cntnap2) Cntnap2-/- | Reduction in PV+ neurons in striatum and cortex at PND14 [15], PV downregulation in striatal Pvalb neurons at PND25 [16] | n/a | Decreased excitatory and inhibitory inputs onto mPFC L2/3 pyramidal neurons, concurrent with reduced spines and synapses [17], reduced long-range and local functional connectivity in prefrontal and midline brain "connectivity hubs" [18], major connectivity deficits in prefrontal and limbic pathways developing between adolescence and adulthood [19] | 2 (S) |
neuroligin 3 (Nlgn3) Nlgn3R451C | Asymmetric “patchy” PV-deficit in cortex at PND >60 [20] | n/a | Reduction in neuron firing synchrony in dissociated cultures of rat hippocampal neurons caused by a decrease in the complexity of axonal architecture [21] | 2 |
fragile X mental retardation protein (Fmr1) Fmr1-/- | PV+ neurons reduced in somatosensory cortex layers II-VI in mice > 1 year [22] | Increased mitochondrial ROS production, impaired complex I activity, and increased mtDNA deletions in fibroblasts from Fmr1 KI mice (described in [3]) [23], mitochondria isolated from dfmr1-/- Drosophila thoraces show increased maximum electron transport system capacity under supersaturating conditions [24] | Anatomical hyperconnectivity in the primary visual cortex (V1), but a disproportional low connectivity of V1 with other neocortical regions [25], hyperconnectivity between neighbouring layer 5 pyramidal neurons during a critical period in early mPFC development [26], but robust hypoconnectivity phenotype in cortico-cortical and cortico-striatal circuits in PND30 mice [19] | 3 (S) |
Parvalbumin (Pvalb) PV+/- and PV-/- | ≈30% reduction of PV+ cells in PV+/- mice in mPFC, SSC and striatum, no changes in numbers of Pvalb neurons in PV+/- and PV-/- mice at PND25 [2] | Increase in mitochondria volume and density in soma of Pvalb neurons and increased density and length of dendritic mitochondria in absence of PV expression [this study] | Increase in dendrite length (DG) and branching (striatum), as well as thickness of proximal dendrites (molecular layer interneurons) of selected PV-/- Pvalb neurons (age 3 – 5 months) [this study] | 5 |
Valproic acid (VPA) Treatment | Asymmetric PV deficit in cortex/hippocampus at PND >60 [20], PV downregulation in striatal Pvalb neurons at PND25 [27] | The antioxidant resveratrol shown to improve the mitochondria function of cells reverses decreases in gephryn expression observed in VPA-treated rats and restores the proportion of PV+ cells in the amygdala [28] | Increased synaptophysin immunostaining in mPFC and a synaptophysin deficit in all hippocampal subfields [29], enhancement of the local recurrent functional connectivity formed by neocortical pyramidal neurons, but diminished number of putative synaptic contacts in connections between layer 5 pyramidal neurons [30] | n/a |